These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9231312)

  • 21. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
    J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder.
    Storch EA; Bussing R; Small BJ; Geffken GR; McNamara JP; Rahman O; Lewin AB; Garvan CS; Goodman WK; Murphy TK
    Behav Res Ther; 2013 Dec; 51(12):823-9. PubMed ID: 24184429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    Greist JH; Jefferson JW; Kobak KA; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowtiz MR; Lydiard B
    Int Clin Psychopharmacol; 1995 Jun; 10(2):57-65. PubMed ID: 7673657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
    Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
    Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP; Sobhan MA
    Pak J Pharm Sci; 2013 Jan; 26(1):95-8. PubMed ID: 23261733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
    Greist J; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowitz M; Lydiard RB; Rasmussen S; White K
    Arch Gen Psychiatry; 1995 Apr; 52(4):289-95. PubMed ID: 7702445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
    Lydiard RB
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():33-7. PubMed ID: 7963449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
    Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
    JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Response to sertraline in adolescents with obsessive-compulsive disorder].
    Rodríguez-Ramos P; Mardomingo Sanz MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):17-21. PubMed ID: 9549132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.
    Koran LM; Ringold AL; Elliott MA
    J Clin Psychiatry; 2000 Jul; 61(7):514-7. PubMed ID: 10937610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials.
    Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB
    Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
    Besiroglu L; Çetinkaya N; Selvi Y; Atli A
    Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder.
    Skarphedinsson G; Weidle B; Ivarsson T
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):574-9. PubMed ID: 26348088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
    Greist JH; Jefferson JW; Kobak KA; Katzelnick DJ; Serlin RC
    Arch Gen Psychiatry; 1995 Jan; 52(1):53-60. PubMed ID: 7811162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder.
    Neziroglu F; Yaryura-Tobias JA; Walz J; McKay D
    J Child Adolesc Psychopharmacol; 2000; 10(4):295-306. PubMed ID: 11191690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of obsessive compulsive disorder in the elderly: a review and case example.
    Calamari JE; Faber SD; Hitsman BL; Poppe CJ
    J Behav Ther Exp Psychiatry; 1994 Jun; 25(2):95-104. PubMed ID: 7983229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open trial and discontinuation study of fluoxetine in children and adolescents with obsessive-compulsive disorder.
    Semerci ZB; Unal F
    Turk J Pediatr; 2001; 43(4):323-8. PubMed ID: 11765163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.